# Altimmune, Inc.: Form 8-K, filed Sep 26, 2024

- Company: [Altimmune, Inc.](/companies/alt.md) (CIK 1326190)
- Form: 8-K
- Filed: 2024-09-26
- Accepted by EDGAR: Sep 26, 2024, 16:45 ET
- Period: 2024-09-26
- Accession: 0001326190-24-000042
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000042/alt-20240926x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326190/000132619024000042/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326190/000132619024000042/alt-20240926x8k.htm

Filed Sep 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001326190-24-000042. Last ingested by Listed: Nov 14, 2026, 20:51 ET. No prices; not investment advice.
